This suggests GLPs may offer protective benefits for the heart that are independent of body size
Supplied as lyophilized powder for reconstitution, this vial is intended for in-vitro research and qualified clinic protocols where lower-concentration delivery is preferred including dose-escalation studies, tolerability baselines, and pilot metabolic investigations
This vote does not change what a pharmacy can compound tomorrow
Current evidence does not support routine clinical use of GLP-1 medications specifically for alcohol cravings, and patients with alcohol use disorder should be referred to evidence-based treatments including behavioral interventions, mutual support groups, and FDA-approved pharmacotherapies such as naltrexone, acamprosate, and disulfiram
To date, just 13 state Medicaid programs cover GLP-1s to treat obesity, while all states cover the drugs to treat diabetes